12-Month Angiographic and Clinical Results of the ReZolve® Sirolimus-Eluting Bioresorbable Coronary Scaffold: The RESTORE trial

被引:0
|
作者
Abizaid, Alexandre
Brachmann, Johannes [1 ]
Costa, Jose D., Jr. [2 ]
Dudek, Dariusz [3 ]
Frey, Norbert [4 ]
Heigert, Matthias [5 ]
Lutz, Matthias [6 ]
Schmermund, Axel [7 ]
Anderson, Jeffrey [8 ]
机构
[1] Klinikum Coburg, Coburg, Germany
[2] Inst Dante Pazzanese Cardiol, Sao Paulo, Brazil
[3] Univ Hosp, Krakow, Poland
[4] Univ Med Ctr Schleswig Holstein, Kiel, Germany
[5] Klin Innere Med Kardiol & Internist Intens Med, Salburg, Austria
[6] Univ Klinikum Schleswig Holstein, Kiel, Germany
[7] Cardioangiol Ctr Bethanien, Frankfurt, Germany
[8] Reva Med, San Diego, CA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:B13 / B13
页数:1
相关论文
共 50 条
  • [41] ABSORB Cohort B Trial: Two Year Clinical and Angiographic Results of the ABSORB Bioresorbable Everolimus Eluting Vascular Scaffold
    Ormiston, Jhon
    Serruys, Patrick W.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (20) : B66 - B66
  • [42] Outcomes of biodegradable polymer sirolimus-eluting PROLIM stent in patients with coronary artery disease. Results of 12-month follow-up of prospective registry
    Roleder, Tomasz
    Smolka, Grzegorz
    Podolecka, Ewa
    Chudek, Jolanta
    Dworowy, Sebastian
    Zelazowska, Katarzyna
    Wojakowski, Wojciech
    Ochala, Andrzej
    KARDIOLOGIA POLSKA, 2016, 74 (05) : 411 - 417
  • [43] Evaluation of the Second Generation of a Bioresorbable Everolimus-Eluting Vascular Scaffold for the Treatment of De Novo Coronary Artery Stenosis 12-Month Clinical and Imaging Outcomes
    Serruys, Patrick W.
    Onuma, Yoshinobu
    Dudek, Dariusz
    Smits, Pieter C.
    Koolen, Jacques
    Chevalier, Bernard
    de Bruyne, Bernard
    Thuesen, Leif
    McClean, Dougal
    van Geuns, Robert-Jan
    Windecker, Stephan
    Whitbourn, Robert
    Meredith, Ian
    Dorange, Cecile
    Veldhof, Susan
    Hebert, Karine Miquel
    Sudhir, Krishnankutty
    Garcia-Garcia, Hector M.
    Ormiston, John A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (15) : 1578 - 1588
  • [44] First-in-human evaluation of a novel sirolimus-eluting ultra-high molecular weight APTITUDE bioresorbable scaffold: 9-and 24-month imaging and clinical results of the RENASCENT II trial
    Chieffo, Alaide
    Khawaja, Saud A.
    Latib, Azeem
    Vesga, Boris
    Moncada, Miguel
    Delgado, Juan A.
    Fonseca, Jaime
    Testa, Luca
    Esposito, Giovanni
    Ferrone, Marco
    Cortese, Bernardo
    Maehara, Akiko
    Granada, Juan F.
    Colombo, Antonio
    EUROINTERVENTION, 2020, 16 (02) : E133 - U122
  • [45] Safety and efficacy of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent for the treatment of de novo coronary lesions: 12-month results from the TARGET II trial
    Xu Bo
    Zhao Yelin
    Yang Yuejin
    Zhang Ruiyan
    Li Hui
    Ma Changsheng
    Chen Shaoliang
    Wang Jianan
    Huo Yong
    Leon, Martin B.
    Gao Runlin
    CHINESE MEDICAL JOURNAL, 2014, 127 (06) : 1027 - 1032
  • [46] Imaging and 2-year clinical outcomes of thin strut sirolimus-eluting bioresorbable vascular scaffold: The MeRes-1 extend trial
    Abizaid, Alexandre
    Kedev, Sasko
    Ali, Rosli Bin Mohd
    Santoso, Teguh
    Cequier, Angel
    van Geuns, Robert-Jan Van Geuns
    Chevalier, Bernard
    Hellig, Farrel
    Costa, Ricardo
    Onuma, Yoshinobu
    Costa Jr, Jose Ribamar
    Serruys, Patrick
    Bangalore, Sripal
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2021, 98 (06) : 1102 - 1110
  • [47] A Next-Generation Bioresorbable Coronary Scaffold System: From Bench to First Clinical Evaluation 6-and 12-Month Clinical and Multimodality Imaging Results
    Verheye, Stefan
    Ormiston, John A.
    Stewart, James
    Webster, Mark
    Sanidas, Elias
    Costa, Ricardo
    Costa, J. Ribamar, Jr.
    Chamie, Daniel
    Abizaid, Andrea S.
    Pinto, Ibraim
    Morrison, Lynn
    Toyloy, Sara
    Bhat, Vinayak
    Yan, John
    Abizaid, Alexandre
    JACC-CARDIOVASCULAR INTERVENTIONS, 2014, 7 (01) : 89 - 99
  • [48] ABSORB Cohort B Trial: 18 Month Clinical and MSCT Results of the ABSORB Bioresorbable Everolimus Eluting Vascular Scaffold
    Serruys, Patrick W.
    Ormiston, John
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (20) : B7 - B7
  • [49] Clinical and Angiographic Outcomes With Sirolimus-Eluting Stents in Total Coronary Occlusions The ACROSS/TOSCA-4 (Approaches to Chronic Occlusions With Sirolimus-Eluting Stents/Total Occlusion Study of Coronary Arteries-4) Trial
    Kandzari, David E.
    Rao, Sunil V.
    Moses, Jeffrey W.
    Dzavik, Vladimir
    Strauss, Bradley H.
    Kutryk, Michael J.
    Simonton, Charles A.
    Garg, Jyotsna
    Lokhnygina, Yuliya
    Mancini, G. B. John
    Yeoh, Eunice
    Buller, Christopher E.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2009, 2 (02) : 97 - 106
  • [50] Nine-month angiographic and two-year clinical follow-up of polymer-free sirolimus-eluting stent versus durable-polymer sirolimus-eluting stent for coronary artery disease: the Nano randomized trial
    Zhang Yaojun
    Chen Fang
    Muramatsu, Takashi
    Xu Bo
    Li Zhanquan
    Ge Junbo
    He Qing
    Yang Zhijian
    Li Shumei
    Wang Lefeng
    Wang Haichang
    He Ben
    Li Kang
    Qi Guoxian
    Li Tianchang
    Zeng Hesong
    Peng Jianjun
    Jiang Tieming
    Zeng Qiutang
    Zhu Jianhua
    Fu Guosheng
    Bourantas, Christos V.
    Serruys, Patrick W.
    Huo Yong
    CHINESE MEDICAL JOURNAL, 2014, 127 (11) : 2153 - 2158